Skip to main content

The effect of 4-hexylresocinol administration on SCC-9 cells: mass spectrometric identification of proteins and cDNA microarray analysis



In stress situations, bacteria produce dormancy-inducing factors to stop cell growth. The dormancy-inducing factors may have an inhibitory effect on tumor cell growth. Here we analyzed the differentially expressed protein profiles after 4-hexylresorcinol (4HR), one of the dormancy-inducing factors, administration using in vitro oral squamous carcinoma cells (SCC-9).


The control group was SCC-9 cells culture without 4HR administration. The experimental group received 10 μg/mL of 4HR. Collected proteins from each group were loaded for 2D electrophoresis. Among the separated proteins, 20 differentially expressed proteins were selected and processed for LC-MS/MS.


In proteomic analysis, the expression of keratin 1, keratin 10, and histone H2B were increased. In cDNA microarray assay, the genes related to the cellular differentiation (involucrin, keratin 13, 14) were highly expressed in the 4HR treated group (fold ratio > 2.0; Table 2). Interestingly, histone family was upregulated in the cDNA microarray assay.


The administration of 4HR on SCC-9 cells increased epithelial cell differentiation markers and histone.


Alkylresorcinols, natural non-isoprenoid lipids found in various plant and bacterial species, attract attention because of a variety of biological functions including non-specific antioxidants, antimutagens, and regulatory molecules of proliferation [1]. Chemical analogs of such lipids exert the anticancer effects as already have been proved in animal models for colon [2], lung [3], and pancreas tumors [4], mononuclear cell leukemia, hepatocellular neoplasms, and circulatory system tumors [5] without clear mechanism. The demonstrations of a potential anti-tumor effect of alkylresorcinols and their non-specificity to various tumors made us eager to undertake studies for elucidating 4-hexylresorcinol (4HR) action on oral squamous cell carcinoma (OSCC).

OSCC is a common malignant cancer, and the overall cure rate has not been improved for decades despite recent development of cancer therapeutics [6]. The drug resistance of OSCC is explained by heterogenous population of OSCC, and it is related to “field cancerization” theory [7]. If the drug has dual functions such as inducing apoptosis of active proliferating cancer cells and redifferentiation of cancer cells which escape from the apoptosis, the therapeutic effects will be increased in the heterogenous OSCC. Therefore, the chemical revertant which can inhibit cancer through induction of cancer differentiation must be developed for OSCC to improve the overall cure rate.

We believe that eukaryotic cells might also produce similar chemical analogs, and these chemicals might help to survive in the micro-environmental stress situation. Starving condition increases the sensitivity to cancer treatment and the survival of normal cells [8]. Therefore, it is reasonable to suggest that mechanisms of 4HR action, same analogy to the regulation of physiological state and activity in microorganisms, will be similar to cancer cells showing inhibition of cell proliferation. Since the anti-tumorigenic effect of 4HR has been suggested by the national toxicology program [9], 4HR-mediated anti-tumor mechanism has been illuminated. 4HR inhibits transglutaminase-2 activity [10] and subsequent nuclear factor-kappaB (NF-κB) signaling pathway [11]. 4HR stimulates the differentiation of oral cancer cells via E2F and Sp1-mediated pathways [12]. 4HR suppresses calcium oscillation in oral cancer cells [13].

The objective of this study was to determine differentially expressed proteins in SCC-9 cells after 4HR administration.


Cell cultures

SCC-9 cells from the American Type Culture Collection (ATCC; Manassas, VA) were grown to confluence in Ham’s F12/Dulbecco’s modified Eagle’s medium (Gibco, BRL, Gaithersburg, MD) containing 1% penicillin/streptomycin, fibroblast growth factor-2 (100 μg/ml), and 10% fetal calf serum (FCS). 4HR (Sigma, St. Louis, MO) was added to confluent cells to final concentrations at 10 μg/mL (50 μM).

Sample analysis by liquid chromatograph-tandem mass spectrometer (LC-MS/MS)

Analytical 2-D electrophoresis and in-gel proteolytic digestion were followed by Doucette and Li [14] and Gharahdaghi’s method [15], respectively. The final tryptic digested peptides were resolved with 7 μl deionized water (DW) in 0.1% formic acid. DW and HPLC-grade acetonitrile were used for the preparation of eluents. Chromatographic separations were performed using a Nano LC 1D system (Eksigent Technologies, CA, USA). Samples (6 μL) were injected directly onto a 150 um × 150 mm column (Vydac 218MS5, 1515; Grace Vydac, Hesperia, CA, USA) and eluted with a linear gradient of 1–80% acetonitrile (0.1% formic acid) in 120 min. Fused-silica 20 μm i.d. tubings were used for pre- and post-column liquid connections. The spots from each individual digest were analyzed by tandem mass spectrometry (MS/MS) using the QqTOF mass spectrometer (QSTAR XL, Applied Biosystems/MDS Sciex, Foster Citys, CA, USA). The built-in IDA method was used for automatic “Rolling Collision Energy” [16].

cDNA microarray

cDNA microarray analysis was performed by Genomic Tree Co. (Daejeon, Korea) using Agilent’s human whole genome 4 X 44 K chips (Santa Clara, CA). After12-hour treatment with or without 4HR (10 μg/mL) in SCC-9, total RNA was extracted using TRI Reagent as recommended by the manufacturer (Molecular Research Center, Inc. Cincinnati, OH).

MTT assay

The respiratory activity in the control and 4HR-treated cultures was assessed as previously described [17]: they were incubated in 6-well multiplates with yellow tetrazolium salt 3-(4, 5-dimethylthiazole-2-yl)-2,5-diphenyltetrazolium bromide (MTT) solution (Cell proliferation kit I; Roche Molecular Biochemicals) for 4 hours at room temperature. Formazan crystals were solubilized overnight, and the product was quantified spectrophotometrically by measuring absorbance at 590 nm using a Victor Multilabel counter (Perkin-Elmer-Wallac, Freiburg, Germany).


In proteomic analysis, the expression of keratin 1, keratin 10, and histone H2B were increased in 2-D gel electrophoresis and they were identified by Quadrupole-time of flight (Q-TOF) (Fig. 1 and Table 1). Interestingly, keratin 1 showed as 2 spots and they were shown conflicting expression patterns. Spot 8 and spot 14 were identified as keratin 1 (Fig. 1). According to MS analysis, spot 8 showed 8 amino acid matching, and spot 14 showed 12 amino acid matching. The molecular weight of spot 8 was smaller than spot 14. Therefore, highly expressed keratin 1 in the control might be a defective protein. Considering that SCC-9 has poorly differentiated cells, keratin expression could have a defect. In the cDNA microarray assay, the genes related to the cellular differentiation (involucrin, keratin 13, 14) were highly expressed in the 4HR treated group (fold ratio > 2.0; Table 2). Interestingly, histone family was upregulated in the cDNA microarray assay. The genes related to calcium channel and caspase were significantly increased (fold ratio > 2.0). However, the genes related to cell cycle, cellular proliferation, and gene transcription were generally decreased their expression (fold ratio<-2.0). We tested the effect of 4HR on cancer cell proliferation. As shown in Fig. 2, 4HR significantly inhibited cell proliferation with the profound effect from 5 μg/ml (p < 0.05).

Fig. 1

Two-dimensional gel electrophoresis and proteomic analysis. SCC-9 cells were cultured to confluency and treated with 4HR-treated (100 μg/ml) for 24 h. Cell lysates were analyzed by 2D gel electrophoresis. Differential expression protein spots were observed in 2D electrophoregrams from control (A, C, E, G) and SCC-9 cells (B, D, F, H). Highly expressed keratin 1 (D), keratin 10 (F), and histone H2B protein (H2BFN) (H) in 4HR treated cells were identified by quadrupole-time of flight mass spectrometry. Arrows 1, 2, and 3 indicated keratin 1, keratin 10, and H2BFN, respectively

Table 1 The results of two-dimensional electrophoresis and Q-tof
Table 2 The results of cDNA microarray. The genes of interest were shown among the genes which showed significant changes at 12 h after 4HR application (10 μg/mL)
Fig. 2

The results of the MTT assay. The cell proliferation assay and the inhibition of respiratory activity. The results of the MTT assay showed a significant decrease in viable cell number in SCC-9 (*P < 0.05 compared to control)


In this study, 4HR accelerated carcinoma epithelial cell differentiation showing upregulation of involucrin and keratins expression (Fig. 1 and Table 2). 4HR increased the expression of histone family in both proteomic analysis (Fig. 1) and cDNA microarray assay (Table 2). Although this study focused on SCC-9 cells and OSCC, we also observed the inhibitory action of 4HR on breast carcinoma cell lines [18]. Besides, 4HR inhibited cell proliferation-related genes including cyclin C and other RNA polymerases by cDNA microarray assay (Table 2). Cyclins may be an important target for 4HR mediated antiproliferative actions. Supportively, 4HR also inhibits cell proliferation of ras oncogene transformed fibroblasts not in normal fibroblasts [19].

4HR also increases epithelial cell differentiation in SCC-9 cells showing the upregulation of various keratins and involucrin, which is observed both in vitro SCC-9 cell culture system and in vivo SCC-9 cell implanted xenograft model [12]. We further confirmed the upregulation of keratins and involucrin by cDNA microarray and proteomic analysis (Fig. 1 and Table 2). Interestingly, 4HR increased several voltage-dependent calcium channels (Table 2). Indeed, 4HR stimulates intracellular calcium uptake [13]. 4HR mediated increase of calcium uptake is due partly to the upregulation of calcium channels (Table 2). Finding the evidence of tumor cell differentiation is very important because it will minimize host damage induced by conventional therapy. Therefore, the study on the chemically induced tumor differentiation should be encouraged. However, it is far behind to explain the mechanism of 4HR mediated acceleration of SCC-9 cell differentiation.

Mechanistically, 4HR mediated various effects on cancer cells may be due in part to the different expression of unidentified 4HR receptors in tumor cells compared to control cells. We do not know the 4HR receptor and its signal transduction pathways except the increase of calcium level at this moment [13]. The increase of calcium uptake by 4HR is the only known phenomenon at this moment with regard to the signaling pathway [13]. Intracellular calcium is broadly related to cell proliferation, differentiation, and apoptosis. Blocking of calcium channels attenuated 4HR mediated antiproliferative and apoptotic effects on cancer cell lines [13]. Interestingly, the elevated calcium level by 4HR seems similar to the increase of intracellular content of calcium in bacterial cells by 4HR [20]. An increase of calcium uptake by 4HR may be an essential step for various biological effects on cells. Importantly, an increase in the intracellular calcium may result in changes of the expression of differentiation markers [21]. According to the known concepts, tumorigenesis is a cellular dedifferentiation and the intracellular signal pathway is directed to the uncontrolled growth [22]. Tumor growth and development are coupled with down-regulation of differentiation-related calcium binding or modulating genes [23], so it can be assumed a positive relationship between tumorigenesis and down-regulation of these genes. Regarding that, the cellular differentiation is largely dependent on calcium [24] and the observed effects of 4HR is due to the increase of its intracellular level in SCC-9 cells. Revertant function of 4HR may be dependent on the increase of calcium uptake because an increased calcium uptake stimulates the cellular differentiation in the normal keratinocytes [24, 25]. Other signal molecules or downstream target molecules may play an important role for 4HR-mediated cellular effects. Protein kinase C-α, for example, plays an important role in calcium-induced keratinocytes differentiation [26]. It is definitely necessary to pursue the precise molecular mechanism of 4HR mediated antitumor effects.

Noteworthy, the action of 4HR is dose-dependent: being introduced at relatively high doses (5-10 μg/mL), 4HR caused the rupture of cellular membranes in cells and possessed cytotoxic action [12]. This is similar to the effect of conventional anti-cancer drugs that are usually toxic and induce apoptosis in cancer cells where DNA looks as fragmented material and protein synthesis is inhibited [27]. However, the antiproliferative effect of 4HR at low concentration (1 μg/mL) is not followed by appearance of cytotoxicity or apoptosis signs [12]. In similar concentrations (0.1-1 mM), 4HR and resveratrol are not cytotoxic to human lymphocytes [28]. As for the potential use of 4HR as an anti-cancer drug, we have to mention the previous toxicology and carcinogenesis studies demonstrating that the oral administration of 4HR in doses up to 650–1000 mg/kg to animals unaffected their survival [9]. In the Zebra fish study, the administration of 4HR in doses up to 1 mM (194 μg/ml) is not teratogenic to the developing embryo [18]. The effective dose of 4HR, used for injections of carcinoma-grafted nude mice, was 10 mg/kg body weight, i.e., two orders of magnitude less, and caused no toxic side effects in our in vivo experiments [12]. They showed the similar action of 4HR on SCC-9 cells xenografted nude mice model, that is, the significant deceleration of tumor growth and the elicitation promotion of cellular differentiation followed by the formation of keratinous matrix in which individual cells underwent contact inhibition [12].

The clinical use of 4HR or cognate substances should require a careful selection of active doses. This is important not only to controlling the type of biological effect but also to avoid a side effect since a prolonged use of 4HR may cause nephropathy and osteosclerosis [29], which can be explained based on 4HR-induced increase of intracellular calcium [13]. Historically, 4HR was used for the therapeutic drug for infectious disease and its solution in olive oil had been taken by human without any complication [27, 28]. Now, it is a component of topical antiseptics on oral mucosa (C0691518: information was derived from the NIH UMLS). In some bacterial species, extracellular alkylresorcinols play as regulatory factors, are accumulated in developing microbial cultures and, when reaching a threshold level, entering them to the stationary phase. Further increase in alkylresorcinol concentration elicits entering of bacteria to a dormant state followed by the formation of morphologically distinct cyst-like cells [30]. Similar analogy, opportunistic pathogens, such as Pseudomonas aeruginosa, produce N-(3-oxo-dodecanoyl) homoserine lactone which selectively impairs the regulation of NF-kB functions in activated mammalian cells [31].


In this study, the administration of 4HR on SCC-9 cells increased epithelial cell differentiation markers such as involucrin and keratins. The expression of histone was also increased by 4HR administration.

Availability of data and materials

Data sharing is not applicable to this article since no dataset was generated or analyzed during the current study.





Oral squamous cell carcinoma


Nuclear factor-kappaB


Liquid chromatograph-tandem mass spectrometer


  1. 1.

    Kozubek A, Tyman JHP (1999) Resorcinolic lipids, the natural non-isoprenoid phenolic amphiphiles and their biological activity. Chem Rev 99(1):1–25.

    Article  PubMed  Google Scholar 

  2. 2.

    Mutoh M, Takahashi M, Fukuda K, Matsushima-Hibiya Y, Mutoh H, Sugimura T, Wakabayashi K (2000) Suppression of cyclooxygenase-2 promoter-dependent transcription activity in colon cancer cells by chemopreventive agents with a resorcin-type structure. Carcinogenesis 21(5):959–963.

    Article  PubMed  Google Scholar 

  3. 3.

    Hasegawa R, Furukawa F, Toyoda K, Takahashi M, Hayashi Y, Hirose M, Ito N (1990) Inhibitory effect of antioxidants on N-bis(2-hydroxypropyl)nitrosamine-induced lung carcinogenesis in rats. Jpn J Cancer Res 81(9):871–877.

    Article  PubMed  PubMed Central  Google Scholar 

  4. 4.

    Maruyama H, Amamura T, Nakae D, Tsutsumi M, Kondo S, Tsujiuchi T, Denda A, Konishi Y (1991) Effect of catechol and its analogs on pancreatic carcinogenesis initiated by N-nitrosobis(2-oxopropyl)amine in Syrian hamsters. Carcinogenesis 12(7):1331–1334.

    Article  PubMed  Google Scholar 

  5. 5.

    Chhabra RS, Huff JE, Haseman J, Hall A, Baskin G, Cowan M (1988) Inhibition of some spontaneous tumors by 4-hexylresorcinol in F344/N rats and B6C3F1 mice. Fundam Appl Toxicol 11(4):685–690.

    Article  PubMed  Google Scholar 

  6. 6.

    Chin D, Boyle GM, Porceddu S, Theile DR, Parsons PG, Coman WB (2006) Head and neck cancer: past, present and future. Expert Rev Anticancer Ther 6(7):1111–1118.

    Article  PubMed  Google Scholar 

  7. 7.

    Braakhuis BJ, Tabor MP, Kummer JA, Leemans CR, Brakenhoff RH (2003) A genetic explanation of Slaughter's concept of field cancerization: evidence and clinical implications. Cancer Res 63(8):1727–1730

    PubMed  Google Scholar 

  8. 8.

    Grossi F, Aita M (2007) Bevacizumab and non-small-cell lung cancer: starving the enemy to survive. Expert Opin Biol Ther 7(7):1107–1119.

    Article  PubMed  Google Scholar 

  9. 9.

    Program NT (1988) NTP toxicology and carcinogenesis studies of 4-hexylresorcinol (CAS No. 136-77-6) in F344/N Rats and B6C3F1 Mice (Gavage Studies). Natl Toxicol Program Tech Rep Ser 330:1–166

    Google Scholar 

  10. 10.

    Kim SG, Jeong JH, Park YW, Song JY, Kim AS, Choi JY, Chae WS (2011) 4-Hexylresorcinol inhibits transglutaminase-2 activity and has synergistic effects along with cisplatin in KB cells. Oncol Rep 25(6):1597–1602.

    Article  PubMed  Google Scholar 

  11. 11.

    Kim SG, Lee SW, Park YW, Jeong JH, Choi JY (2011) 4-Hexylresorcinol inhibits NF-κB phosphorylation and has a synergistic effect with cisplatin in KB cells. Oncol Rep 26(6):1527–1532

    PubMed  Google Scholar 

  12. 12.

    Kim SG, Kim AS, Jeong JH, Choi JY, Kweon H (2012) 4-Hexylresorcinol stimulates the differentiation of SCC-9 cells through the suppression of E2F2, E2F3 and Sp3 expression and the promotion of Sp1 expression. Oncol Rep 28(2):677–681.

    Article  PubMed  Google Scholar 

  13. 13.

    Kim SG, Choi JY (2013) 4-Hexylresorcinol exerts antitumor effects via suppression of calcium oscillation and its antitumor effects are inhibited by calcium channel blockers. Oncol Rep 29(5):1835–1840.

    Article  PubMed  Google Scholar 

  14. 14.

    Doucette A, Li L (2001) Investigation of the applicability of a sequential digestion protocol using trypsin and leucine aminopetidase M for protein identification by matrix-assisted laser desorption/ ionization-time of flight mass spectrometry. Proteomics 1(8):987–1000.<987::AID-PROT987>3.0.CO;2-5

    Article  PubMed  Google Scholar 

  15. 15.

    Gharahdaghi F, Weinberg CR, Meagher DA, Imai BS, Mische SM (1999) Mass spectrometric identification of proteins from silver-stained polyacrylamide gel: a method for the removal of silver ions to enhance sensitivity. Electrophoresis 20(3):601–605.<601::AID-ELPS601>3.0.CO;2-6

    Article  PubMed  Google Scholar 

  16. 16.

    Ens W, Standing KG (2005) Hybrid quadrupole/time-of-flight mass spectrometers for analysis of biomolecules. Methods Enzymol 402:49–78.

    Article  PubMed  Google Scholar 

  17. 17.

    Mulyukin AL, Demkina EV, Kozlova AN, Soina VS, El’-Registan GI (2001) Synthesis of anabiosis autoinducers by non-spore-forming bacteria as a mechanism regulating their activity in soil and subsoil sedimentary rocks. Microbiol 70(5):535–541.

    Article  Google Scholar 

  18. 18.

    Kang YJ, Oh JH, Seok H, Jo YY, Kim DW, Garagiola U, Choi JY, Kim SG (2020) 4-Hexylresorcinol exhibits different characteristics to estrogen. Appl Sci 10(5):1737.

    Article  Google Scholar 

  19. 19.

    Il’inskaya ON, Kolpakov AI, Mulyukin AL, Dreyer F, El’-Registan GI (2000) Effects of membrane-active microbial autoregulators on the growth of cultured ras-transformed fibroblasts. Appl Biochem Microbiol 36(5):473–477.

    Article  Google Scholar 

  20. 20.

    Mulyukin AL, Sorokin VV, Loiko NG, Suzina NE, Duda VI, Vorob’eva EA, El’-Registan GI (2002) Comparative study of the elemental composition of vegetative and resting microbial cells. Microbiol 71(1):31–40.

    Article  Google Scholar 

  21. 21.

    Worthen LM, Nollert MU (2000) Intracellular calcium response of endothelial cells exposed to flow in the presence of thrombin or histamine. J Vasc Surg 32(3):593–601.

    Article  PubMed  Google Scholar 

  22. 22.

    Wakefield LM, Roberts AB (2002) TGF-β signaling: positive and negative effects on tumorigenesis. Curr Opin Genet Dev 12(1):22–29.

    Article  PubMed  Google Scholar 

  23. 23.

    Luo A, Kong J, Hu G, Liew CC, Xiong M, Wang X, Ji J, Wang T, Zhi H, Wu M, Liu Z (2004) Discovery of Ca2+-relevant and differentiation-associated genes downregulated in esophageal squamous cell carcinoma using cDNA microarray. Oncogene 23(6):1291–1299.

    Article  PubMed  Google Scholar 

  24. 24.

    Rodland KD (2004) The role of the calcium-sensing receptor in cancer. Cell Calcium 35(3):291–295.

    Article  PubMed  Google Scholar 

  25. 25.

    Sakaguchi M, Miyazaki M, Takaishi M, Sakaguchi Y, Makino E, Kataoka N, Yamada H, Namba M, Huh NH (2003) S100C/A11 is a key mediator of Ca2+-induced growth inhibition of human epidermal keratinocytes. J Cell Biol 163(4):825–835.

    Article  PubMed  PubMed Central  Google Scholar 

  26. 26.

    Yang LC, Ng DC, Bikle DD (2003) Role of protein kinase Cα in calcium induced keratinocyte differentiation: defective regulation in squamous cell carcinoma. J Cellular Physiol 195(2):249–259.

    Article  Google Scholar 

  27. 27.

    Leonard V (1925) The significance of hexylresorcinol and its homologues in relation to the problem of internal antisepsis. Science 62(1610):408–412.

    Article  PubMed  Google Scholar 

  28. 28.

    Young CC, Damon SR (1927) Laboratory: the use of hexylresorcinol in the treatment of typhoid carriers. Am J Public Health 17(3):279–280.

    Article  Google Scholar 

  29. 29.

    Robinson HM Jr (1967) Effective antifungal drugs and indications for their use. Med Clin North Am 51(5):1181–1188.

    Article  PubMed  Google Scholar 

  30. 30.

    El'-Registan GI, Tsyshnatii GV, Duzha MV, Pronin SV, Mitiushina LL (1980) Regulation of Pseudomonas carboxydoflava growth and development by specific endogenous factors. Mikrobiologiia 49(4):561–565

    PubMed  Google Scholar 

  31. 31.

    Kravchenko VV, Kaufmann GF, Mathison JC, Scott DA, Katz AZ, Grauer DC, Lehmann M, Meijler MM, Janda KD, Ulevitch RJ (2008) Modulation of gene expression via disruption of NF-kB signaling by a bacterial small molecule. Science 321(5886):259–262.

    Article  PubMed  Google Scholar 

Download references


Authors appreciated to Dr. Chang-Hoon Chae for his help on this experiment.


This work was carried out without funding support.

Author information




YJH collected the data and wrote the manuscript. KSG revised original manuscript and edited figures. The authors read and approved the final manuscript.

Corresponding author

Correspondence to Seong-Gon Kim.

Ethics declarations

Ethics approval and consent to participate

Not applicable.

Consent for publication

Not applicable.

Competing interests

Authors declare that they have no competing interests. KSG is an editorial board member of “Maxillofacial Plastic and Reconstructive Surgery.”

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Kang, YJ., Kim, SG. The effect of 4-hexylresocinol administration on SCC-9 cells: mass spectrometric identification of proteins and cDNA microarray analysis. Maxillofac Plast Reconstr Surg 43, 28 (2021).

Download citation


  • 4-hexylresorcinol
  • Oral squamous cell carcinoma
  • Keratin
  • Histone